{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:17:54Z","timestamp":1758125874067,"version":"3.37.3"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Mayo Foundation and NIH","award":["31155"],"award-info":[{"award-number":["31155"]}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2014-04234"],"award-info":[{"award-number":["RGPIN-2014-04234"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.toxlet.2018.05.027","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T16:39:41Z","timestamp":1527007181000},"page":"193-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome"],"prefix":"10.1016","volume":"294","author":[{"given":"Klaus","family":"Klarskov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Racine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Luc","family":"Boudreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Normandin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Marsault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald J.","family":"Gleich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2018.05.027_bib0005","unstructured":"Akashiba, T., Nakayama, A. and Murata, A. (1982). Process for Producing L- Tryptophan, A Pure Culture of a Microorganism Strain used in Said Process. USA Patent 4,363,875. December 14th, 1982."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199008093230601","article-title":"An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use","volume":"323","author":"Belongia","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.nu.12.070192.001315","article-title":"The eosinophilia myalgia syndrome and tryptophan","volume":"12","author":"Belongia","year":"1992","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0020","series-title":"Cases in Field Epidemiology: A Global Perspective","first-page":"313","article-title":"Toxic tryptophan? Investigating the eosinophilia-myalgia syndrome in Minnesota","author":"Belongia","year":"2004"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-2275(20)33352-6","article-title":"Rapid separation and identification of phosphatidylethanolamine molecular species","volume":"40","author":"Brouwers","year":"1999","journal-title":"J. Lipid Res."},{"year":"2017","series-title":"Lipid Web: Saturated Branched-Chain Fatty Acids","author":"Christie","key":"10.1016\/j.toxlet.2018.05.027_bib0030"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0035","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1039\/C5NP00073D","article-title":"Fragmentation reactions using electrospray ionization mass spectrometry: an important tool for the structural elucidation and characterization of synthetic and natural products","volume":"33","author":"Demarque","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/metabo6040046","article-title":"Current and future perspectives on the structural identification of small molecules in biological systems","volume":"6","author":"Dias","year":"2016","journal-title":"Metabolites"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0140-6736(90)90421-Z","article-title":"L-tryptophan and eosinophilia-myalgia syndrome in New Mexico","volume":"335","author":"Eidson","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0050","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1021\/jp0374915","article-title":"Gas-phase fragmentation reactions of protonated aromatic amino acids: concomitant and consecutive neutral eliminations and radical cation formations","volume":"108","author":"El Aribi","year":"2004","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1289\/ehp.02110457","article-title":"The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge","volume":"5","author":"Gelpi","year":"2002","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd1011","article-title":"The basics of mass spectrometry in the twenty-first century","volume":"2","author":"Glish","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0065","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1248\/cpb.40.2236","article-title":"3-anilino-L-alanine, structural determination of UV-5, a contaminant in EMS-associated L-tryptophan samples","volume":"40","author":"Goda","year":"1992","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0070","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/978-1-4615-4709-9_63","article-title":"Tryptophan toxicity-time and dose response in rats","volume":"467","author":"Gross","year":"1999","journal-title":"Adv. Expt. Med. Biol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jasms.2004.11.008","article-title":"A New charge-associated mechanism to account for the production of fragment ions in the High-energy CID spectra of fatty acids","volume":"16","author":"Harvey","year":"2005","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0080","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.chroma.2010.01.036","article-title":"Structure and absolute configuration of an unsaturated anteiso fatty acid from bacillus megaterium","volume":"1217","author":"Hauff","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0085","first-page":"273","article-title":"Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan","volume":"20","author":"Henning","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0090","first-page":"867","article-title":"The eosinophilia-myalgia syndrome: the Los alamos conference","volume":"18","author":"Hertzman","year":"1991","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0095","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/archinte.161.19.2301","article-title":"Rigorous New approach to constructing a Gold standard for validating New diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome","volume":"161","author":"Hertzman","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00230724","article-title":"Contaminants in L-tryptophan associated with eosinophilia- myalgia syndrome","volume":"25","author":"Hill","year":"1993","journal-title":"Arch. Environ. Contam. Toxicol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in t helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor Crth2","volume":"193","author":"Hirai","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.1992.03480010085029","article-title":"Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients","volume":"267","author":"Kamb","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0115","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0735-1097(91)90794-A","article-title":"Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome","volume":"18","author":"Kilbourne","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/oxfordjournals.epirev.a036085","article-title":"Eosinophilia-myalgia syndrome: coming to grips with a New illness","volume":"14","author":"Kilbourne","year":"1992","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0125","article-title":"Structural of a contaminant in L-tryptophan associated with eosinophilia-myalgia syndrome Long Beach, California, USA","author":"Klarskov","year":"2000","journal-title":"48Th American Society for Mass Spectrometry and Allied Topics Meeting, June 11-15Th, 2000"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.toxlet.2017.10.012","article-title":"Structure determination of disease associated Peak AAA from L- tryptophan implicated in the eosinophilia-myalgia syndrome","volume":"282","author":"Klarskov","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jasms.2003.09.011","article-title":"Gas-phase reactions of protonated tryptophan","volume":"15","author":"Lioe","year":"2004","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-113-2-124","article-title":"The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology","volume":"113","author":"Martin","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0145","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.2270484","article-title":"Characterization of \u2018Peak E\u2019, a novel amino acid associated with eosinophilia-myalgia syndrome","volume":"250","author":"Mayeno","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0150","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0025-6196(12)61142-2","article-title":"3-(phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalagia syndrome: a link to the toxic oil syndrome?","volume":"67","author":"Mayeno","year":"1992","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0167-7799(94)90035-3","article-title":"The eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale","volume":"12","author":"Mayeno","year":"1994","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0160","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/tx00049a003","article-title":"Biotransformation of 3-(phenylamino)-1,2-propanediol to 3- (phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome","volume":"8","author":"Mayeno","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0165","first-page":"350","article-title":"Characterization of By-products in L-Tryptophan","volume":"14","author":"Muller","year":"1991","journal-title":"Bioforum"},{"year":"2015","series-title":"Tandem Mass Spectrometry of Lipids: Molecular Analysis of Complex Lipids","author":"Murphy","key":"10.1016\/j.toxlet.2018.05.027_bib0170"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/pme.10.16","article-title":"Unraveling human complexity and disease with systems biology and personalized medicine","volume":"7","author":"Naylor","year":"2010","journal-title":"Pers. Med."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0180","series-title":"National Eosinophilia-Myalgia Syndrome Network; December 2017 Newsletter","article-title":"Eosinophilia myalgia syndrome contaminants: past, present, future","author":"Naylor","year":"2017"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10238-006-0096-5","article-title":"Is the L-tryptophan metabolite quinolinic acid responsible for eosinophilic fasciitis?","volume":"6","author":"Noakes","year":"2006","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0190","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/metabo3020312","article-title":"Applying tandem mass spectral libraries for solving the critical assessment of small molecule identification (CASMI) LC\/MS challenge 2012","volume":"3","author":"Oberacher","year":"2013","journal-title":"Metabolites"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/oxfordjournals.aje.a116841","article-title":"Tryptophan contaminants associated with eosinophilia-myalgia syndrome","volume":"138","author":"Philen","year":"1993","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1194\/jlr.D020651","article-title":"Structural characterization of saturated branched chain fatty acid methyl esters by collisional dissociation of molecular ions generated by electron ionization","volume":"53","author":"Ran-Ressler","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0205","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1044-0305(01)00220-3","article-title":"Effects of ionization Mode on charge-site- remote and related fragmentation reactions of Long-Chain quaternary ammonium ions","volume":"12","author":"Seto","year":"2001","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0210","series-title":"Tryptophan, Serotonin, and Melatonin: Basic Aspects and Applications","first-page":"469","article-title":"Synthesis, formation and occurrence of contaminants in biotechnologically manufactured L- tryptophan","author":"Simat","year":"1999"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jama.1990.03450020065028","article-title":"Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer","volume":"264","author":"Slutsker","year":"1990","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0220","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-2275(20)37381-8","article-title":"Reversed-phase High performance liquid chromatography of phosphatidylcholine: a simple method for determining relative hydrophobic interact- ion of various molecular species","volume":"22","author":"Smith","year":"1981","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0225","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0040-4039(00)74469-8","article-title":"1,1\u2019-ethyl-idenebis(L-tryptophan), structure determination of contaminant \u201897\u2019-implicated in the eosinophilia-myalgia syndrome (EMS)","volume":"32","author":"Smith","year":"1991","journal-title":"Tetrahedron. Lett."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0230","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00011-005-1380-7","article-title":"A heretofore-undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation","volume":"54","author":"Smith","year":"2005","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0235","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.1990.03450130070029","article-title":"Eosinophilia-myalgia syndrome: results of national surveillance","volume":"264","author":"Swygert","year":"1990","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0240","first-page":"1711","article-title":"Eosinophilia-myalgia syndrome: mortality data from the US national surveillance system","volume":"20","author":"Swygert","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0245","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1248\/cpb.39.820","article-title":"Characterization of contaminants in EMS-associated L-tryptophan samples by High performance liquid chromatography","volume":"39","author":"Toyo\u2019oka","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0021-9673(93)80450-M","article-title":"Separation and isolation of trace impurities in L- tryptophan by High performance liquid chromatography","volume":"630","author":"Trucksess","year":"1993","journal-title":"J. Chromatogr."},{"year":"2004","series-title":"COT Statement on Tryptophan and the Eosinophilia-Myalgia Syndrome, Committee on the Toxicity of Chemicals in Food, Consumer Products and the Environment, United Kingdom","author":"UK Committee on Toxicology (COT)","key":"10.1016\/j.toxlet.2018.05.027_bib0255"},{"year":"2018","series-title":"Personal Communication That Included Discussions With Patients\/ Board Members of the National Eosinophilia-Myalgia Syndrome Network (NEMSN-","author":"Vierk","key":"10.1016\/j.toxlet.2018.05.027_bib0260"},{"key":"10.1016\/j.toxlet.2018.05.027_bib0265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-4274(97)00048-9","article-title":"On-line HPLC tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia- myalgia syndrome","volume":"92","author":"Williamson","year":"1997","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0270","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1099-0801(199809\/10)12:5<255::AID-BMC743>3.0.CO;2-E","article-title":"Rapid HPLC screening method for contaminants found in implicated L-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome","volume":"12","author":"Williamson","year":"1998","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-4274(98)00223-9","article-title":"On-line HPLC tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia-myalgia syndrome","volume":"99","author":"Williamson","year":"1998","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2018.05.027_bib0280","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s11746-002-0625-0","article-title":"Effect of fatty acid Chain length on Normal- and reversed-phase HPLC of phospholipids","volume":"79","author":"Zhai","year":"2002","journal-title":"J. Am. Oil Chem. Soc."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418302236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418302236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:45:00Z","timestamp":1661301900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427418302236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":56,"alternative-id":["S0378427418302236"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.05.027","relation":{},"ISSN":["0378-4274"],"issn-type":[{"type":"print","value":"0378-4274"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}